These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27542674)

  • 41. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
    Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
    BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-522 contributes to cell proliferation of hepatocellular carcinoma by targeting DKK1 and SFRP2.
    Zhang H; Yu C; Chen M; Li Z; Tian S; Jiang J; Sun C
    Tumour Biol; 2016 Aug; 37(8):11321-9. PubMed ID: 26960688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
    Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma.
    Xie BH; He X; Hua RX; Zhang B; Tan GS; Xiong SQ; Liu LS; Chen W; Yang JY; Wang XN; Li HP
    Cancer Biomark; 2016; 16(3):405-13. PubMed ID: 27062697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma.
    Zhang Y; Yao J; Huan L; Lian J; Bao C; Li Y; Ge C; Li J; Yao M; Liang L; He X
    Cancer Lett; 2015 Jan; 356(2 Pt B):978-84. PubMed ID: 25444921
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-138 inhibits cell proliferation in hepatocellular carcinoma by targeting Sirt1.
    Luo J; Chen P; Xie W; Wu F
    Oncol Rep; 2017 Aug; 38(2):1067-1074. PubMed ID: 28677784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
    Huang X; Qin J; Lu S
    Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-21 promotes cell proliferation in human hepatocellular carcinoma partly by targeting HEPN1.
    Hu S; Tao R; Wang S; Wang C; Zhao X; Zhao H; Li L; Zhu S; He Y; Jiang X; Gao Y
    Tumour Biol; 2015 Jul; 36(7):5467-72. PubMed ID: 25687183
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
    He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
    Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
    Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
    Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of proliferation, angiogenesis and apoptosis in hepatocellular carcinoma by miR-26b-5p.
    Wang Y; Sun B; Sun H; Zhao X; Wang X; Zhao N; Zhang Y; Li Y; Gu Q; Liu F; Shao B; An J
    Tumour Biol; 2016 Aug; 37(8):10965-79. PubMed ID: 26891666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
    Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
    Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells.
    Li J; Fu H; Xu C; Tie Y; Xing R; Zhu J; Qin Y; Sun Z; Zheng X
    BMC Cancer; 2010 Jul; 10():354. PubMed ID: 20602797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following Treatment with Dendrosomal Nanocurcumin.
    Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
    Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.